A Phase 1, Open-Label, Mass Balance Study Assessing the Pharmacokinetics of [14C]Ponatinib After a Single Oral Dose in Healthy Male Volunteers

Trial Profile

A Phase 1, Open-Label, Mass Balance Study Assessing the Pharmacokinetics of [14C]Ponatinib After a Single Oral Dose in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jul 2017

At a glance

  • Drugs Ponatinib (Primary)
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Biliary cancer; Chronic myeloid leukaemia; Gastrointestinal stromal tumours; Lung cancer; Solid tumours; Squamous cell cancer; Thyroid cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 08 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top